HW English
Headlines

Headlines: Covaxin Gets EUA From India’s Drugs Controller For 2-18 Years Age Kids

An expert panel on Tuesday recommended Covaxin – Bharat Biotech’s COVID-19 vaccine – for use on children between the ages of two and 18. That final approval – viewed as a formality – will be given by the Drug Controller General of India. When it does come, Covaxin will be only the second vaccine cleared for use on kids in India; in August Zydus Cadila’s three-dose DNA jab was allowed to be used on adults and children over 12.

#Covaxin #BharatBiotech #CovidVaccine #EmergencyUseAuthorization

HW News Live TV

Related posts

NCPCR Asks Netflix To Stop Streaming Bombay Begums In 24Hr,Cites Inappropriate Portrayal of children

News Desk

Headlines: “We diluted Article 370 twelve times without any controversy,” claims Congress

Arti Ghargi

Headlines: Big Setback For CAA Protestors, SC Bench Headed By CJI Bobde Refuses To Put A Stay

Arti Ghargi